Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Potential Role for Urine Polymerase Chain Reaction in the Diagnosis of Whipple's Disease.

Moter A, Janneck M, Wolters M, Iking-Konert C, Wiessner A, Loddenkemper C, Hartleben B, Lütgehetmann M, Schmidt J, Langbehn U, Janssen S, Geelhaar-Karsch A, Schneider T, Moos V, Rohde H, Kikhney J, Wiech T.

Clin Infect Dis. 2018 Oct 22. doi: 10.1093/cid/ciy664. [Epub ahead of print]

PMID:
30351371
2.

Whipple's Disease: Diagnostic Value of rpoB Gene PCR from Peripheral Blood Mononuclear Cells.

Weigt K, Wiessner A, Moter A, Fenollar F, Raoult D, Allers K, Schneider T, Moos V.

Mol Diagn Ther. 2018 Jun 7. doi: 10.1007/s40291-018-0339-7. [Epub ahead of print]

PMID:
29882197
3.

Cell-Associated Simian Immunodeficiency Virus Accelerates Initial Virus Spread and CD4+ T-Cell Depletion in the Intestinal Mucosa.

Allers K, Kunkel D, Hofmann J, Stahl-Hennig C, Moos V, Schneider T.

J Infect Dis. 2018 Apr 11;217(9):1421-1425. doi: 10.1093/infdis/jiy055.

PMID:
29390066
4.

Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon.

Bücker R, Krug SM, Moos V, Bojarski C, Schweiger MR, Kerick M, Fromm A, Janßen S, Fromm M, Hering NA, Siegmund B, Schneider T, Barmeyer C, Schulzke JD.

Mucosal Immunol. 2018 Mar;11(2):575-577. doi: 10.1038/mi.2017.78. Epub 2017 Nov 1.

PMID:
29091080
5.

Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon.

Bücker R, Krug SM, Moos V, Bojarski C, Schweiger MR, Kerick M, Fromm A, Janßen S, Fromm M, Hering NA, Siegmund B, Schneider T, Barmeyer C, Schulzke JD.

Mucosal Immunol. 2018 Mar;11(2):474-485. doi: 10.1038/mi.2017.66. Epub 2017 Aug 2. Erratum in: Mucosal Immunol. 2017 Nov 01;:.

PMID:
28766554
6.

Peripheral T-Cell Reactivity to Heat Shock Protein 70 and Its Cofactor GrpE from Tropheryma whipplei Is Reduced in Patients with Classical Whipple's Disease.

Trotta L, Weigt K, Schinnerling K, Geelhaar-Karsch A, Oelkers G, Biagi F, Corazza GR, Allers K, Schneider T, Erben U, Moos V.

Infect Immun. 2017 Jul 19;85(8). pii: e00363-17. doi: 10.1128/IAI.00363-17. Print 2017 Aug.

7.

Architectural and functional alterations of the small intestinal mucosa in classical Whipple's disease.

Epple HJ, Friebel J, Moos V, Troeger H, Krug SM, Allers K, Schinnerling K, Fromm A, Siegmund B, Fromm M, Schulzke JD, Schneider T.

Mucosal Immunol. 2017 Nov;10(6):1542-1552. doi: 10.1038/mi.2017.6. Epub 2017 Feb 8.

PMID:
28176790
8.

More than meets the eye.

Blessin UB, Fischer A, Schneider T, Moos V, Müller T, Weylandt KH, Pleyer U.

Gut. 2018 Jan;67(1):69. doi: 10.1136/gutjnl-2016-312390. Epub 2016 Dec 20. No abstract available.

PMID:
27998986
9.

Usage of Murine T-cell Hybridoma Cells as Responder Cells Reveals Interference of Helicobacter Pylori with Human Dendritic Cell-mediated Antigen Presentation.

Fehlings M, Drobbe L, Beigier-Bompadre M, Viveros PR, Moos V, Schneider T, Meyer TF, Aebischer T, Ignatius R.

Eur J Microbiol Immunol (Bp). 2016 Dec 1;6(4):306-311. eCollection 2016 Dec 1.

10.

Distribution and Activation of CD8+ T Cells in the Duodenal Mucosa before and after HIV Seroconversion.

Allers K, Puyskens A, Epple HJ, Schürmann D, Hofmann J, Moos V, Schneider T.

J Immunol. 2017 Jan 1;198(1):481-491. Epub 2016 Nov 21.

11.

Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients.

Neumann L, Mueller M, Moos V, Heller F, Meyer TF, Loddenkemper C, Bojarski C, Fehlings M, Doerner T, Allers K, Aebischer T, Ignatius R, Schneider T.

J Immunol. 2016 Sep 1;197(5):1801-8. doi: 10.4049/jimmunol.1501330. Epub 2016 Jul 25.

12.

Tropheryma whipplei infection and Whipple's disease.

Marth T, Moos V, Müller C, Biagi F, Schneider T.

Lancet Infect Dis. 2016 Mar;16(3):e13-22. doi: 10.1016/S1473-3099(15)00537-X. Epub 2016 Feb 6. Review.

PMID:
26856775
13.

Essential Nonredundant Function of the Catalytic Activity of Histone Deacetylase 2 in Mouse Development.

Hagelkruys A, Mattes K, Moos V, Rennmayr M, Ringbauer M, Sawicka A, Seiser C.

Mol Cell Biol. 2015 Nov 23;36(3):462-74. doi: 10.1128/MCB.00639-15. Print 2016 Feb 1.

14.

Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of Leptospirosis.

Volz MS, Moos V, Allers K, Luge E, Mayer-Scholl A, Nöckler K, Loddenkemper C, Jansen A, Schneider T.

Clin Vaccine Immunol. 2015 Dec;22(12):1276-84. doi: 10.1128/CVI.00397-15. Epub 2015 Oct 21.

15.

Cardiac myxoma secreting interleukin-6 promotes cavitary tuberculosis: a case report.

Volz MS, Loddenkemper C, Morguet A, Moos V, Schneider T.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1265-6. doi: 10.5588/ijtld.15.0405. No abstract available.

PMID:
26459552
16.

-295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease.

Biagi F, Schiepatti A, Badulli C, Sbarsi I, Trotta L, Feurle GE, Müller C, Moos V, Schneider T, Marth T, De Amici M, Martinetti M, Corazza GR.

Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1919-21. doi: 10.1007/s10096-015-2433-7. Epub 2015 Jul 8.

PMID:
26154181
17.

The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients.

Allers K, Puyskens A, Epple HJ, Schürmann D, Hofmann J, Moos V, Schneider T.

Mucosal Immunol. 2016 Jan;9(1):265-74. doi: 10.1038/mi.2015.58. Epub 2015 Jul 1.

PMID:
26129649
18.

A case series in patients with enteropathy and granulomatous diseases.

Kruis T, Jöhrens K, Moos V, Puls I, Siegmund B, Daum S, Schumann M.

BMC Gastroenterol. 2015 May 23;15:62. doi: 10.1186/s12876-015-0292-4.

19.

[S2k-guideline gastrointestinal infectious diseases and Whipple's disease].

Hagel S, Epple HJ, Feurle GE, Kern WV, Lynen Jansen P, Malfertheiner P, Marth T, Meyer E, Mielke M, Moos V, von Müller L, Nattermann J, Nothacker M, Pox C, Reisinger E, Salzberger B, Salzer HJ, Weber M, Weinke T, Suerbaum S, Lohse AW, Stallmach A; Weitere Mitglieder der Leitlinienkommission sind am Ende des Beitrags gelistet.

Z Gastroenterol. 2015 May;53(5):418-59. doi: 10.1055/s-0034-1399337. Epub 2015 May 12. German. No abstract available.

20.

Gastrointestinal diagnosis of classical Whipple disease: clinical, endoscopic, and histopathologic features in 191 patients.

Günther U, Moos V, Offenmüller G, Oelkers G, Heise W, Moter A, Loddenkemper C, Schneider T.

Medicine (Baltimore). 2015 Apr;94(15):e714. doi: 10.1097/MD.0000000000000714.

21.

[Tropheryma whipplei: pathogen of Whipple's disease and more].

Schneider T, Moos V.

Dtsch Med Wochenschr. 2015 Mar;140(6):428-32. doi: 10.1055/s-0041-100846. Epub 2015 Mar 16. Review. German.

PMID:
25774735
22.

[Whipple's disease].

Moos V, Schneider T.

Dtsch Med Wochenschr. 2014 Dec;139(49):2507-9. doi: 10.1055/s-0034-1387401. Epub 2014 Nov 25. Review. German. No abstract available.

PMID:
25423457
23.

Role of dendritic cells in the pathogenesis of Whipple's disease.

Schinnerling K, Geelhaar-Karsch A, Allers K, Friebel J, Conrad K, Loddenkemper C, Kühl AA, Erben U, Ignatius R, Moos V, Schneider T.

Infect Immun. 2015 Feb;83(2):482-91. doi: 10.1128/IAI.02463-14. Epub 2014 Nov 10.

24.

Effect of age on the CD4⁺ T-cell impairment in HIV-infected persons without and with cART.

Allers K, Bösel D, Epple HJ, Karcher H, Schmidt W, Kunkel D, Geelhaar-Karsch A, Schinnerling K, Moos V, Schneider T.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):7-15. doi: 10.1097/QAI.0000000000000097.

PMID:
24378723
25.

Inflammatory myopathy with abundant macrophages (IMAM): the immunology revisited.

Rinnenthal JL, Goebel HH, Preuße C, Lebenheim L, Schumann M, Moos V, Schneider T, Heppner FL, Stenzel W.

Neuromuscul Disord. 2014 Feb;24(2):151-5. doi: 10.1016/j.nmd.2013.11.004. Epub 2013 Nov 18.

PMID:
24314585
26.

Macrophages accumulate in the gut mucosa of untreated HIV-infected patients.

Allers K, Fehr M, Conrad K, Epple HJ, Schürmann D, Geelhaar-Karsch A, Schinnerling K, Moos V, Schneider T.

J Infect Dis. 2014 Mar 1;209(5):739-48. doi: 10.1093/infdis/jit547. Epub 2013 Oct 16.

PMID:
24133185
27.

Validation of an rpoB gene PCR assay for detection of Tropheryma whipplei: 10 years' experience in a National Reference Laboratory.

Moter A, Schmiedel D, Petrich A, Wiessner A, Kikhney J, Schneider T, Moos V, Göbel UB, Reischl U.

J Clin Microbiol. 2013 Nov;51(11):3858-61. doi: 10.1128/JCM.01703-13. Epub 2013 Aug 21.

28.

The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23.

Weinhold M, Eisenblätter M, Jasny E, Fehlings M, Finke A, Gayum H, Rüschendorf U, Renner Viveros P, Moos V, Allers K, Schneider T, Schaible UE, Schumann RR, Mielke ME, Ignatius R.

PLoS One. 2013 Jun 21;8(6):e65934. doi: 10.1371/journal.pone.0065934. Print 2013.

29.

Evaluation of arginine metabolism for the analysis of M1/M2 macrophage activation in human clinical specimens.

Geelhaar-Karsch A, Schinnerling K, Conrad K, Friebel J, Allers K, Schneider T, Moos V.

Inflamm Res. 2013 Sep;62(9):865-9. doi: 10.1007/s00011-013-0642-z. Epub 2013 Jun 18.

PMID:
23775039
30.

Immunopathology of immune reconstitution inflammatory syndrome in Whipple's disease.

Moos V, Feurle GE, Schinnerling K, Geelhaar A, Friebel J, Allers K, Moter A, Kikhney J, Loddenkemper C, Kühl AA, Erben U, Fenollar F, Raoult D, Schneider T.

J Immunol. 2013 Mar 1;190(5):2354-61. doi: 10.4049/jimmunol.1202171. Epub 2013 Jan 30.

31.

Tropheryma whipplei genotypes 1 and 3, Central Europe.

Wetzstein N, Fenollar F, Buffet S, Moos V, Schneider T, Raoult D.

Emerg Infect Dis. 2013 Feb;19(2):341-2. doi: 10.3201/eid1902.120709. No abstract available.

32.

Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease.

Feurle GE, Moos V, Bläker H, Loddenkemper C, Moter A, Stroux A, Marth T, Schneider T.

J Infect. 2013 Mar;66(3):263-70. doi: 10.1016/j.jinf.2012.12.004. Epub 2013 Jan 3.

PMID:
23291038
33.

Cytokine genetic profile in Whipple's disease.

Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Mytilineos J, Garlaschelli F, Marchese A, Trotta L, Bianchi PI, Di Stefano M, Cremaschi AL, De Silvestri A, Salvaneschi L, Martinetti M, Corazza GR.

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3145-50. doi: 10.1007/s10096-012-1677-8. Epub 2012 Jul 31.

PMID:
22847580
34.

Ion transport and barrier function are disturbed in microscopic colitis.

Barmeyer C, Erko I, Fromm A, Bojarski C, Allers K, Moos V, Zeitz M, Fromm M, Schulzke JD.

Ann N Y Acad Sci. 2012 Jul;1258:143-8. doi: 10.1111/j.1749-6632.2012.06631.x.

PMID:
22731727
35.

Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes.

Fehlings M, Drobbe L, Moos V, Renner Viveros P, Hagen J, Beigier-Bompadre M, Pang E, Belogolova E, Churin Y, Schneider T, Meyer TF, Aebischer T, Ignatius R.

Infect Immun. 2012 Aug;80(8):2724-34. doi: 10.1128/IAI.00381-12. Epub 2012 May 21.

36.

The role of T cells in the pathogenesis of classical Whipple's disease.

Moos V, Schneider T.

Expert Rev Anti Infect Ther. 2012 Mar;10(3):253-5. doi: 10.1586/eri.12.4. No abstract available.

PMID:
22397556
37.

The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole.

Feurle GE, Moos V, Schneider T, Fenollar F, Raoult D.

J Antimicrob Chemother. 2012 May;67(5):1295-6. doi: 10.1093/jac/dks008. Epub 2012 Jan 27. No abstract available.

PMID:
22287233
38.

High frequency of Tropheryma whipplei in culture-negative endocarditis.

Geissdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, Morguet AJ, Fenollar F, Raoult D, Bogdan C, Schneider T.

J Clin Microbiol. 2012 Feb;50(2):216-22. doi: 10.1128/JCM.05531-11. Epub 2011 Nov 30.

39.

Modulation of the CD4+ T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol α-glucoside content.

Beigier-Bompadre M, Moos V, Belogolova E, Allers K, Schneider T, Churin Y, Ignatius R, Meyer TF, Aebischer T.

J Infect Dis. 2011 Nov;204(9):1339-48. doi: 10.1093/infdis/jir547. Epub 2011 Sep 15.

PMID:
21921201
40.

Regulatory T cells in patients with Whipple's disease.

Schinnerling K, Moos V, Geelhaar A, Allers K, Loddenkemper C, Friebel J, Conrad K, Kühl AA, Erben U, Schneider T.

J Immunol. 2011 Oct 15;187(8):4061-7. doi: 10.4049/jimmunol.1101349. Epub 2011 Sep 14.

41.

[Tropheryma whipplei infection. Colonization, self-limiting infection and Whipple's disease].

Moos V, Loddenkemper C, Schneider T.

Pathologe. 2011 Sep;32(5):362-70. doi: 10.1007/s00292-011-1446-y. Review. German.

PMID:
21667114
42.

Changing paradigms in Whipple's disease and infection with Tropheryma whipplei.

Moos V, Schneider T.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1151-8. doi: 10.1007/s10096-011-1209-y. Epub 2011 Apr 2. Review.

PMID:
21461659
43.

The immune reconstitution inflammatory syndrome in whipple disease: a cohort study.

Feurle GE, Moos V, Schinnerling K, Geelhaar A, Allers K, Biagi F, Bläker H, Moter A, Loddenkemper C, Jansen A, Schneider T.

Ann Intern Med. 2010 Dec 7;153(11):710-7. doi: 10.7326/0003-4819-153-11-201012070-00004.

PMID:
21135294
44.

Specific and nonspecific B-cell function in the small intestines of patients with Whipple's disease.

Geelhaar A, Moos V, Schinnerling K, Allers K, Loddenkemper C, Fenollar F, LaScola B, Raoult D, Schneider T.

Infect Immun. 2010 Nov;78(11):4589-92. doi: 10.1128/IAI.00705-10. Epub 2010 Aug 9.

45.

Interferon-gamma and T-bet expression in a patient with toxoplasmic lymphadenopathy.

Jöhrens K, Moos V, Schneider T, Stein H, Anagnostopoulos I.

Hum Immunol. 2010 Apr;71(4):366-71. doi: 10.1016/j.humimm.2010.01.005. Epub 2010 Jan 25.

PMID:
20074601
46.

Gut mucosal FOXP3+ regulatory CD4+ T cells and Nonregulatory CD4+ T cells are differentially affected by simian immunodeficiency virus infection in rhesus macaques.

Allers K, Loddenkemper C, Hofmann J, Unbehaun A, Kunkel D, Moos V, Kaup FJ, Stahl-Hennig C, Sauermann U, Epple HJ, Schneider T.

J Virol. 2010 Apr;84(7):3259-69. doi: 10.1128/JVI.01715-09. Epub 2010 Jan 13.

47.

T-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy-cell leukemia correlates with interferon-gamma production.

Jöhrens K, Moos V, Schneider T, Anagnostopoulos I.

Leuk Lymphoma. 2009 Oct;50(10):1687-92. doi: 10.1080/10428190903161042.

PMID:
19757302
48.

Impaired immune functions of monocytes and macrophages in Whipple's disease.

Moos V, Schmidt C, Geelhaar A, Kunkel D, Allers K, Schinnerling K, Loddenkemper C, Fenollar F, Moter A, Raoult D, Ignatius R, Schneider T.

Gastroenterology. 2010 Jan;138(1):210-20. doi: 10.1053/j.gastro.2009.07.066. Epub 2009 Aug 5.

PMID:
19664628
49.

The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease.

Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Marchese A, Trotta L, Sachetto S, Pasi A, De Silvestri A, Salvaneschi L, Corazza GR.

Gastroenterology. 2009 Jun;136(7):2289-94. doi: 10.1053/j.gastro.2009.01.051. Epub 2009 Jan 27.

PMID:
19208355
50.

Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.

Epple HJ, Schneider T, Troeger H, Kunkel D, Allers K, Moos V, Amasheh M, Loddenkemper C, Fromm M, Zeitz M, Schulzke JD.

Gut. 2009 Feb;58(2):220-7. doi: 10.1136/gut.2008.150425. Epub 2008 Oct 20.

PMID:
18936106

Supplemental Content

Support Center